The new lake treasure: 820 million corporate bonds will be paid at the interest rate of 7.9% on August 25th.
On August 15th, () Co., Ltd. announced the interest payment of "20 Xinhu 01" in 2022.
According to the announcement, the 2020 public offering corporate bonds of the new lake treasure Co., Ltd. (Phase I) issued by the new lake treasure on August 25th, 2020 will pay the interest from August 25th, 2021 to August 24th, 2022.
The bond is abbreviated as 20 Xinhu 01, with a total issue amount of 820 million yuan, a bond term of 4 years and a bond interest rate of 7.90%. the new lake treasure has the right to decide whether to adjust the coupon rate of this bond at the end of the second year of its existence.
It is reported that China Securities Depository and Clearing Co., Ltd. Shanghai Branch is the institution for registration, settlement, bond dividend distribution and redemption.
(Editor: Pu Shasha)
The real controller of Dongfang Huanyu intends to reduce its shareholding by no more than 0.26%.
() Announcement was made. On August 16th, the company received the Letter of Notice on Share Reduction Plan issued by Mr. Li Weiwei, the actual controller, director and deputy general manager. Mr. Li Weiwei intends to reduce his holdings of the company’s shares by centralized bidding within six months after 15 trading days from the date of announcement, accounting for no more than 500,000 shares, accounting for no more than 0.26% of the company’s total share capital.
Sino-international alliance plans to set up a Japanese subsidiary to expand overseas business with US$ 5 million.
() Announcement, the company intends to set up a wholly-owned secondary subsidiary (3S Japan Co., Ltd.) in Japan with its own funds through its wholly-owned subsidiary, China International Hong Kong, with a total investment of 5 million US dollars, and provide the company with early working capital; Through the establishment of Japanese companies, technology development, product sales and after-sales service can be realized locally, which is conducive to overseas business development, expanding the company’s business scale and enhancing the company’s profitability.
Dongfang Huanyu: The actual controller intends to reduce the company’s shares by no more than 0.26%.
Dongfang Huanyu announced on the evening of August 16th that Li Weiwei, the company’s actual controller, director and deputy general manager, intends to reduce the company’s shares by no more than 500,000 shares, accounting for no more than 0.26% of the company’s total share capital.
Guo Mao shares: the actual controller and its concerted actions intend to reduce their holdings by no more than 2%.
() On the evening of August 16th, it was announced that Shen Huiping, one of the company’s actual controllers, and Xu Ling, a concerted action person, planned to reduce the company’s shares by no more than 2%.
Shen Huiping, the actual controller of Guo Mao shares, and his concerted actions intend to reduce their holdings by no more than 2%.
Guo Mao Co., Ltd. announced that Ms. Shen Huiping, one of the actual controllers of the company, and Ms. Xu Ling, who acted in concert, reduced their holdings by no more than 13,250,500 shares, and the reduction ratio did not exceed 2.00% of the company’s total share capital. Among them, Ms. Shen Huiping plans to reduce the company’s shares by no more than 3,312,600 shares, with the reduction ratio not exceeding 0.50% of the company’s total share capital, and Ms. Xu Ling plans to reduce the company’s shares by no more than 9,937,900 shares, with the reduction ratio not exceeding 1.50% of the company’s total share capital.
Fudan Fuhua subsidiary participated in bidding for plot 02-04, Fengcheng Town, Fengxian District, Shanghai.
() Announcement: Shanghai Fuhua Zhixian Economic Development Co., Ltd., a holding subsidiary of the company, intends to participate in the listing and transfer of the right to use state-owned construction land in Shanghai, and participate in the bidding for plot 02-04 in Fengcheng Town, Fengxian District on August 17, 2022. The above plot is located in 02-08 plot in the east, Planning Road in the south, Fenggan Highway in the west, and 02-03 plot in the north, with a transfer area of 68,079.4 square meters and a plot ratio of 2.0. The land use is industrial land, the transfer period is 50 years, and the initial listing price is 35.75 million yuan.
Zejing Pharmaceutical Co., Ltd.: The clinical trial of "ZGGS18 for injection" for the treatment of advanced solid tumor was approved.
Zejing Pharmaceutical announced that the company recently received the Notice of Approval for Clinical Trials of Drugs issued by National Medical Products Administration (hereinafter referred to as "National Medical Products Administration"), and the clinical trial of ZGGS18 for injection for the treatment of advanced solid tumors was approved.
It is reported that ZGGS18 is a bifunctional antibody fusion protein drug developed by Gensun Biopharma Inc and its subsidiary through its bispecific antibody research and development platform, and it is also the second bispecific antibody drug submitted by the company for clinical trial application. ZGGS18 is registered and classified as a kind of therapeutic biological product, which is expected to become an innovative biological product for the treatment of solid tumors.
Zejing Pharmaceutical Co., Ltd.: ZGGS18 for injection was approved by the clinical trial.
Zejing Pharmaceutical announced on the evening of August 16th that the company recently received the Notice of Approval for Clinical Trials of Drugs issued by National Medical Products Administration, and the clinical trial of ZGGS18 for injection for the treatment of advanced solid tumors was approved.
Yi Delong plans to set up new companies in Singapore and Vietnam to establish a manufacturing base in Southeast Asia.
() Announcement: In order to further expand overseas markets, optimize procurement and logistics modes, and improve the satisfaction of customers in North America and Europe in terms of comprehensive cost and flexible delivery, Elbow International Co., Ltd., a wholly-owned subsidiary of the company in Hong Kong, plans to use its own funds to establish a new Singapore company (registered capital of 3.05 million US dollars) as a route company, and then invest in a new Vietnam company (registered capital of 3 million US dollars). This foreign investment will establish its own manufacturing base in Southeast Asia.
Yi Delong plans to increase the capital of its Hong Kong subsidiary by US$ 20 million to meet the capacity demand of new orders.
Yi Delong announced that in order to further expand overseas markets, optimize procurement and logistics modes, and improve the satisfaction of customers in North America and Europe in terms of comprehensive cost and flexible delivery, the company plans to use its own funds to increase the capital of its wholly-owned subsidiary, Elubao International Co., Ltd. ("Elubao Company") by 20 million US dollars. After this capital increase, the registered capital of Elubao Company will increase from 4.5 million US dollars to 24.5 million US dollars. The main reason for this capital increase is to meet the capacity demand of new orders and increase capital investment.
Bank of Nanjing: The acquisition of controlling stake in Suning Consumer Finance Co., Ltd. was approved by the regulatory authorities.
On the evening of August 16th, Bank of Nanjing announced that China Banking and Insurance Regulatory Commission agreed that the company would accept 36% equity of Suning Xiaojin held by Suning.cn Group Co., Ltd. and 5% equity of Suning Xiaojin held by Jiangsu Yanghe Winery Co., Ltd. After the completion of the equity change, the company’s shareholding in Suning Xiaojin will increase from 15% to 56%.
Donghu High-tech: Hubei Road and Bridge Consortium won the bid for PPP development and construction project in Dangyang Economic Development Zone Industrial Park.
() Announcement. Recently, Hubei Road and Bridge Group Co., Ltd. (hereinafter referred to as "Hubei Road and Bridge"), a wholly-owned subsidiary of the company, as the leader of the consortium, received the Notice of Winning the Bid for PPP Development and Construction Project of Dangyang Economic Development Zone Industrial Park jointly issued by Hubei Dangyang Economic Development Zone Management Committee (tenderee), Hubei Dejun Construction Project Management Co., Ltd. (tendering agency) and dangyang city Public Resource Trading Center, and won the bid for the PPP development and construction project of Dangyang Economic Development Zone Industrial Park.
Wansheng Co., Ltd.: Trial production of Wansheng Dawei technical transformation project, a wholly-owned subsidiary.
() On the evening of August 16th, it was announced that the technical transformation project of Wansheng Dawei, a wholly-owned subsidiary (with an annual output of 15,000 fatty tertiary amines, 10,000 tons of quaternary ammonium salts and 2,000 tons of electronic-grade trioctylamine) had officially entered the trial production stage.
Wansheng Co., Ltd.: Trial production of "Technical transformation project with an annual output of 27,000 tons of fatty amines and their derivatives"
Wansheng shares announced that Jiangsu Wansheng Dawei Chemical Co., Ltd. ("Wansheng Dawei"), a wholly-owned subsidiary of the company, has completed the main construction of the project and the installation and commissioning of equipment for the technical transformation project with an annual output of 27,000 tons of fatty amine and its derivatives (including electronic-grade trioctylamine, tertiary alkyl amine and quaternary ammonium salt) ("technical transformation project" with an annual output of 15,000 tons of fatty tertiary amine, 10,000 tons of quaternary ammonium salt and 2,000 tons of electronic-grade trioctylamine).
It is reported that Wansheng Dawei fatty amine products can be produced as fabric softeners, shampoos, cosmetics, printing and dyeing auxiliaries, synthetic fiber oil agents, demulsifiers, fungicides, buffers, etc., which are widely used in daily chemical industry, textile industry, petroleum industry, mining industry, transportation industry and other fields. Tertiary fatty amines are derived downstream into quaternary ammonium salts. Quaternary ammonium salts have excellent properties such as stable chemical properties, good dispersion and corrosion inhibition, and at the same time avoid the risk factors of chlorine-containing and oxygen-containing compounds. It is one of the leading directions in the development of disinfectant products in the world and has been widely used in food, cosmetics, textiles, oil fields and industrial water treatment. After the technical transformation project of Wansheng Dawei is put into production, it is beneficial to broaden the downstream product matrix and optimize and expand the company’s amine and daily chemical raw materials sector.
Bank of Nanjing: The acquisition of controlling stake in Suning Consumer Finance Company was approved by the regulatory authorities.
On the evening of August 16th, Bank of Nanjing announced that China Banking and Insurance Regulatory Commission agreed that the company would accept 36% equity of Suning Xiaojin held by Suning.cn Group Co., Ltd. and 5% equity of Suning Xiaojin held by Jiangsu Yanghe Winery Co., Ltd. After the completion of the equity change, the company’s shareholding in Suning Xiaojin will increase from 15% to 56%.
Hongda Co., Ltd.: The production base and holding subsidiary of the headquarters temporarily cut off power and stopped production.
() On the evening of August 16th, it was announced that the non-ferrous production base and phosphorus chemical production base (located in shifang city, Deyang City, Sichuan Province) of the company headquarters and Sichuan Mianzhu Chuanrun Chemical Co., Ltd., the holding subsidiary, were temporarily suspended from August 15th, and the expected suspension time was 24:00 on August 20th. The temporary suspension of production is expected to reduce the output of zinc alloy by about 1,000 tons, phosphorus chemical products by about 4,000 tons and synthetic ammonia by 2,000 tons. At present, the company’s inventory of related products is relatively sufficient, and this temporary suspension of production will not have a significant adverse impact on the company’s operating performance.
The production base and subsidiaries of Hongda Co., Ltd. were temporarily suspended due to the power restriction policy.
Hongda shares announced that in order to implement the emergency notice of Sichuan Provincial Department of Economy and Information Technology and State Grid Sichuan Electric Power Company, it was about "expanding the implementation scope of industrial enterprises transferring electricity to the people in 19 cities (states) in the whole province (except Panzhihua and Liangshan), and implementing a full production stop (except security load) for all industrial power users (including white-listed key security enterprises) in the orderly power utilization scheme of Sichuan Power Grid". The company’s headquarters non-ferrous production base and phosphorus chemical production base (located in shifang city, Deyang City, Sichuan Province) and its holding subsidiary, Sichuan Mianzhu Chuanrun Chemical Co., Ltd. (located in Mianzhu City, Deyang City, Sichuan Province) have temporarily stopped production since August 15, 2022, and the expected production suspension time is 24:00 on August 20, 2022 (subject to the notice of relevant departments).
It is reported that the temporary suspension of production is expected to reduce the output of zinc alloy by about 1,000 tons, phosphorus chemical products by about 4,000 tons and synthetic ammonia by 2,000 tons.
Donghu High-tech: Winning the bid for PPP development and construction project in Dangyang Economic Development Zone Industrial Park.
Donghu High-tech announced on the evening of August 16 that Hubei Luqiao, a wholly-owned subsidiary, as the leader of the consortium, won the bid for the PPP development and construction project in the industrial park of Dangyang Economic Development Zone. According to the approved feasibility study report, the total investment of the project is 1.867 billion yuan. The project adopts BOT operation mode, and the cooperation period of the project is 20 years, including 3 years of construction and 17 years of operation.
Bank of Nanjing: The shareholding ratio of Suning Xiaojin’s controlling stake was increased from 15% to 56%.
On August 16th, Bank of Nanjing announced that recently, Suning Xiaojin received the Reply from the Insurance Regulatory Commission of Bank of China on the Change of Equity of Suning Consumer Finance Co., Ltd. (Yin Bao Jian Fu [2022] No.592), and agreed that the company would accept 36% equity of Suning Xiaojin held by Suning.cn Group Co., Ltd. and 5% equity of Suning Xiaojin held by Jiangsu Yanghe Winery Co., Ltd. After the completion of this equity change, the proportion of shares held by Nanjing Bank in Suning Xiaojin will increase from 15% to 56%.
(Editor: Qian Xiaorui)
120 million restricted shares of Xingfa Group were listed and circulated on August 22nd.
() Announced that the number of restricted shares listed and circulated by the company this time is 120 million shares, and the date of listing and circulation of restricted shares is August 22, 2022.
*ST Hengyu signed a major daily operation contract of 56.56 million yuan.
*ST Hengyu announced that the company recently signed a product sales contract with a European customer. The subject matter of the contract is a 30,000-ton/year industrial continuous waste tire cracking production line, with a total contract amount of 8,366,700 US dollars, about 56.56 million yuan (including tax).
This agreement is a contract for daily business activities. According to the performance schedule agreed in the contract, it will not have a significant impact on the company’s performance in 2022. If this contract is successfully performed, it is expected to have a positive impact on the company’s operating performance in 2023, and at the same time, it will help to enhance the company’s ability to continue to operate and brand influence, and have a positive impact on the company’s exploration of overseas markets.
*ST Hengyu: signed a product sales contract of 56.56 million yuan with a European customer.
*ST Hengyu announced on the evening of August 16th that the company recently signed a product sales contract with a European customer, with a total contract value of USD 8,366,700, or about RMB 56.56 million.
Ai Ai Seiko 2021: It is planned to distribute 0.164 yuan per share, with ex-dividend on August 25th.
() Announce the company’s annual profit distribution plan for 2021: a cash dividend of 0.164 yuan per share (including tax).
The date of record for this equity distribution is August 24, 2022, and the ex-dividend date is August 25, 2022.
Chifeng Gold: Wanxiang Mining has made progress in the general survey of rare earth minerals in the southern mining area of Sepon mine in Laos.
() Announcement: Vientiane Mining Co., Ltd. ("Vientiane Mining"), a holding subsidiary of the company, has the exclusive right to explore and exploit mineral resources within a total area of 1247km, including Sepon Mining Area. At the beginning of 2021, when Wanxiang Mining Company was exploring gold and copper mines in the southern mining area, ionic rare earth ore anomalies were found in the granite distribution area. By studying the geological data and field geological investigation, it was found that the granite weathering crust in this area was rich in ion-adsorbed rare earth, and the prospecting prospect was considerable. From December 2021 to July 2022, Vientiane Mining carried out the general survey of rare earth minerals in this region, and has made progress in stages and compiled the General Survey Report of Rare Earth Minerals in the Southern Mining Area of Sepon Mine in Shawan Naji Province, Laos. The general survey progress of rare earth minerals in the southern mining area of Sepon Mine in Vientiane Mining is announced as follows:
The general survey is carried out within 10km of the southern west area within the exploration right. In the southern western area, two ore bodies were identified by general survey. The ore bodies occurred in granite weathering crust, and the genetic type of the deposit belongs to ion adsorption rare earth deposit of weathering crust. The estimated total economic resources of the two ore bodies are (332+333) 32,047.52 tons, with an estimated area of 9.1km, the average vertical thickness of the ore bodies is 4.83m, and the average grade is 0.045%, of which 332 kinds of total rare earth oxides (TREO) are 8,075.02 tons, accounting for 25.2% of the total resources. Total phase rare earth oxide (TREO) is 23,972.5 tons in 333 categories, accounting for 74.8% of the total resources. The partition of ionic rare earth oxides shows that its partition type belongs to rare medium and heavy rare earth. Analogical evaluation of the technical performance of ore processing and extraction shows that the hydrogeological conditions in the mining area are simple, the engineering geological conditions are simple and the geological environment quality is good.
The internal and external conditions for the development of this mining area are good. In-situ leaching process is used to extract rare earths, which has the advantages of simple production process, low cost, high output and high utilization rate of mineral resources. At present, the control range of drilling engineering in the southern western part of the mining area is about 10km, and the actual exposed area of granite exceeds 50km, so there is great potential for prospecting and increasing reserves in the mining area; In addition, about 330km of granite is exposed in the blank area around the mining area. Therefore, the prospect of weathering crust rare earth prospecting in this area is broad.
Zejing Pharmaceutical’s application for marketing of Donafenib Toluene Sulfonate Tablets was approved.
On the evening of August 15th, Zejing Pharmaceutical announced that its first-class new drug, Donafenib Toluene Sulfonate Tablets (trade name: Zepusheng, hereinafter referred to as "Donafenib"), which was independently developed by Zejing Pharmaceutical, was approved for the marketing of new drugs for the treatment of advanced, locally advanced or metastatic differentiated thyroid cancer. This is the second indication that Donafenib has been approved for marketing after it has been approved for patients with unresectable hepatocellular carcinoma who have not received systemic treatment before.
Donafenib is an oral multi-target and multi-kinase inhibitor small molecule anti-tumor drug independently developed by the company. The marketing approval for the indication of treating advanced, locally advanced or metastatic radioactive iodine refractory differentiated thyroid cancer is mainly based on the results of a multi-center, randomized, double-blind, placebo-controlled phase III clinical trial of Donafenib in the treatment of locally advanced/metastatic radioactive iodine refractory differentiated thyroid cancer (research code ZGDD3). The main effectiveness results show that Donafenib group can significantly reduce the risk of disease progression, significantly prolong the survival time without disease progression and obtain better objective relief compared with placebo group. Detailed data of this clinical trial will be published in international academic journals in due course.
In June 2021, the indications of Donafenib for patients with unresectable hepatocellular carcinoma who have not received systemic treatment before have been approved for marketing. Donafenib has been listed in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2021). At the same time, it has been included in the Health and Health Commission’s Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2022 Edition), Guidelines for Diagnosis and Treatment of Primary Liver Cancer by Chinese Society of Clinical Oncology (CSCO) (2022), Guidelines for Integrated Diagnosis and Treatment of Cancer in China (CACA Guide), Guiding Principles for Clinical Application of New Antitumor Drugs (2021 Edition), and China Expert Consensus on Perioperative Management of Hepatocellular Carcinoma (2021) Expert Consensus on Multidisciplinary Comprehensive Treatment of Liver Cancer in China, Clinical Practice Guidelines for TACE of Liver Cancer in China (2021 Edition) and Radiotherapy Guidelines for Primary Hepatocellular Carcinoma in China (2020 Edition).
Proofread Liu Baoqing
Sichuan Jinding subsidiary temporarily stopped production due to the restriction of electricity policy.
() Announcement is issued, in order to implement the Emergency Notice of Sichuan Provincial Department of Economy and Information Technology and State Grid Sichuan Electric Power Company on Expanding the Implementation Scope of Power Transfer for Industrial Enterprises to the People, the company "expands the implementation scope of power transfer for industrial enterprises to the people in 19 cities (states) in the whole province (except Panzhihua and Liangshan), and implements a full production stop (except security load) for all industrial power users (including white-listed key security enterprises) in the orderly power consumption plan of Sichuan Power Grid. Sichuan Jindingshun Mining Co., Ltd., Sichuan Shuncai Building Materials Co., Ltd. and Sichuan Shuncai Xingshu Calcium Industry Co., Ltd., all wholly-owned subsidiaries of the company, stopped production on August 14, 2022.
Since August 9, 2022, the production and operation of Sichuan Jindingshun Mining Co., Ltd., Sichuan Shuncai Building Materials Co., Ltd. and Sichuan Shuncai Xingshu Calcium Industry Co., Ltd., all wholly-owned subsidiaries of the company, have been affected by the power restriction policy. The company expects that by August 20, 2022, the power cut and shutdown will reduce the company’s limestone production by about 280,000 tons and calcium oxide production by about 20,000 tons, and the estimated net profit attributable to listed companies will be reduced by about 4.49 million yuan.
(): Vanadium products are not the main products of the company, and the revenue generated in 2021 accounts for only 1.28%.
Zhenhua shares announced that the deviation of the closing price of the company’s shares in three consecutive trading days on August 12, August 15 and August 16, 2022 exceeded 20%, which was an abnormal fluctuation of stock trading.
It is reported that the company’s share price has increased greatly recently, and the company is concerned that some media have included the company in the vanadium battery concept stocks. Now the relevant information is as follows: The company is mainly engaged in the research and development, manufacturing and sales of chromium chemicals, vitamin K3 and other chromium salt co-production products, ultrafine aluminum hydroxide and other chromium salt by-products. The company’s vanadium product is a by-product of chromium salt of the company, which does not belong to the company’s main product. In 2021, the operating income of this product was 38.2 million yuan, accounting for 1.28% of the company’s operating income in the same period. This product accounted for a small proportion of the company’s operating income and did not have a significant impact on the company’s operation.
Guanshi Technology: Xianghe Yongyuan and others intend to reduce their holdings by no more than 6%.
() On the evening of August 16th, it was announced that the shareholders of the company, Xianghe Yongyuan, Yongjie Investment, Yongji Huachuang and Haoxin Investment, acted in concert, holding a total of 6.6% of the shares, and planned to reduce their holdings by no more than 6%.
Four shareholders of Guanshi Technology intend to reduce their holdings by no more than 6%.
Guanshi Technology announced that due to its own capital needs, the company’s shareholders Xianghe Yongyuan, Yongjie Investment, Yongji Huachuang and Haoxin Investment intend to reduce their holdings of the company’s shares through centralized bidding and block trading, with a total reduction of no more than 4.386 million shares, accounting for 6.00% of the company’s total share capital.
Dongfang Fashion signed the first examination room operation and maintenance service project with a contract value of 13.8 million yuan.
() Announcement was issued. On July 18th, 2022, the company received the Notice of Winning Bid from shenzhen public Traffic Police Bureau, which confirmed that the company was the successful bidder for the operation and maintenance service project of Yuanshan Examination Room of shenzhen public Traffic Police Bureau. Recently, the company and shenzhen public Traffic Police Bureau formally signed the "2022 Yuanshan Examination Room Operation and Maintenance Service Project Contract" with a total contract amount of 13.8 million yuan.
This contract is the company’s first examination room operation and maintenance service project. If the project can be successfully implemented, it indicates that the company’s operation mode and management experience have been standardized and reproducible, which is of positive significance for the company’s future development.
Kangxinuo sent 8 yuan date of record for every 10 shares on August 22nd.
Kangxinuo announced that the company will distribute the rights and interests of A shares in 2021, and distribute the cash dividend (including tax) to all shareholders for every 10 shares in 8 yuan and date of record on August 22nd.
Xingfa Group subsidiary Xingfu Electronics listed counseling for the record.
Xingfa Group announced that the company received a notice from Hubei Xingfu Electronic Materials Co., Ltd. ("Xingfu Electronics"), a holding subsidiary, on August 16, 2022. On August 15, 2022, Xingfu Electronics handled the initial public offering counseling registration in Hubei Supervision Bureau of China Securities Regulatory Commission ("Hubei Securities Regulatory Bureau"). On the same day, Hubei Securities Regulatory Bureau officially issued a confirmation letter for counseling registration, and the counseling institution was () Co., Ltd.
Xingfa Group subsidiary Xingfu Electronics listed counseling for the record.
Xingfa Group announced that the company received a notice from Hubei Xingfu Electronic Materials Co., Ltd. ("Xingfu Electronics"), a holding subsidiary, on August 16, 2022. On August 15, 2022, Xingfu Electronics handled the initial public offering counseling registration in Hubei Supervision Bureau of China Securities Regulatory Commission ("Hubei Securities Regulatory Bureau"). On the same day, Hubei Securities Regulatory Bureau officially issued a confirmation letter for counseling registration, and the counseling institution was TF Securities Co., Ltd.
From April to June, Vogel Optronics made provision for credit impairment and asset impairment totaling 6.072 million yuan.
() Announce that, according to the Accounting Standards for Business Enterprises and the company’s accounting policies, in order to accurately and objectively reflect the company’s financial status as of June 30, 2022 and its operating results from April to June 2022, the company and its subsidiaries conducted a comprehensive inventory and impairment test on various accounts receivable, other accounts receivable and inventories, and the total provision for credit impairment and asset impairment was RMB 6.072 million from April to June 2022.
Guo Mao shares: Shareholders Shen Huiping and Xu Ling intend to reduce their holdings by no more than 2% in total.
Release on August 16th-Guo Mao announced that shareholders Shen Huiping and Xu Ling intend to reduce their holdings of the company’s shares by no more than 13,250,507 shares in total, with the reduction ratio not exceeding 2.00% of the company’s total share capital.
China Telecom announced the half-year rights distribution plan for 2022, and plans to send 10 1.2 yuan.
() The announcement was made on August 17th, and the contents of the company’s half-year equity distribution plan for 2022 are as follows: based on the total share capital of 77,629,728,700 shares, a cash dividend of RMB 1.20 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 9.316 billion will be distributed, accounting for 50.93% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
According to the semi-annual performance report released by China Telecom in 2022, the company’s operating income was 240.219 billion yuan, a year-on-year increase of 10.42%; The net profit attributable to shareholders of listed companies was 18.291 billion yuan, a year-on-year increase of 3.09%; The basic earnings per share was 0.20 yuan, compared with 0.22 yuan in the same period last year.
China Telecom Co., Ltd. is a leading large-scale comprehensive intelligent information service operator, whose main business is to provide mobile communication services, fixed-line and smart home services, and industrial digital services. The company’s main products and services include personal communication and information service (mobile communication service), home communication and information service (fixed network and smart home service), government-enterprise communication and information service (industrial digitalization). The company’s own brand "Tianyi Cloud" ranks first in the global public cloud IaaS.
(Source: () iFinD)
Wansheng Co., Ltd.: Trial production of subsidiary Wansheng Dawei technical transformation project
On the evening of August 16th, Wansheng Co., Ltd. announced that Jiangsu Wansheng Dawei Chemical Co., Ltd., a wholly-owned subsidiary, had completed the main construction of the project, equipment installation and debugging, and the trial production plan was approved by experts and filed by relevant authorities, which met the trial production conditions and officially entered the trial production stage.
The company said that at present, the project has only entered the trial production stage, and it will take some time from trial operation and production to full production and economic benefits. At the same time, it may also be affected by factors such as changes in market demand environment and intensified competition.
Donghu High-tech: Winning the bid for 1.867 billion yuan PPP development and construction project.
On the evening of August 16, Donghu High-tech announced that Hubei Luqiao, a wholly-owned subsidiary, as the leader of the consortium, won the bid for the PPP development and construction project in the industrial park of Dangyang Economic Development Zone. According to the approved feasibility study report, the total investment of the project is 1.867 billion yuan. The project adopts BOT operation mode, and the cooperation period of the project is 20 years, including 3 years of construction and 17 years of operation.
Chen Lihong, the shareholder of Tianyong Intelligent, has reduced its holdings by 800,800 shares, and the time for reduction has expired.
() Announcement was issued. On August 16, 2022, the company received the Letter of Notice on the Implementation Results of the Reduction Plan of Shanghai Tianyong Intelligent Equipment Co., Ltd. from the shareholder Chen Lihong. By August 16th, 2022, Chen Lihong reduced its holdings of 800,800 shares through call auction, accounting for 0.74% of the total share capital. As of the disclosure date of this announcement, the time interval of this reduction plan expires.
6.66% of Shenzhen Qianhai Rongyao Capital Jiezhi Company, the major shareholder of Anfu Technology.
() Announcement: Shenzhen Qianhai Glory Capital Management Co., Ltd. ("Shenzhen Qianhai Glory"), a shareholder holding 6.66% of the company’s shares, released the pledge of 7,457,200 shares on August 15, 2022, accounting for 6.66% of the company’s total share capital. Shenzhen Qianhai Glory plans to pledge the shares separately after this pledge to support the company’s follow-up financing.
The actual controller of Guo Mao intends to reduce its shareholding by no more than 2%.
Guo Mao shares announced that Shen Huiping, one of the company’s actual controllers, and Xu Ling, a concerted action person, intend to reduce their holdings by no more than 2%.
Yijiahe completed the repurchase of 960,400 shares at a cost of 50,444,800 yuan.
() Announcement was issued. As of August 16th, 2022, the implementation period of the company’s share repurchase has expired. The total number of shares repurchased by the company through centralized bidding transaction is 960,400 shares, accounting for 0.4619% of the company’s total share capital. The highest transaction price is 57.990 yuan/share, and the lowest transaction price is 47.463 yuan/share. The total amount of funds paid is 50,444,800 yuan (. The company’s share repurchase plan has been implemented.
Shenzhen Maoye, the major shareholder of Heavy Drugs Holdings, and its concerted actions reduced their holdings by 1.08%.
() Announcement was issued. On August 15, 2022, the company received the Notice on Reducing the Holding Shares of Heavy Drugs from Shenzhen Maoye (Group) Co., Ltd. ("Shenzhen Maoye"), a shareholder holding more than 5% of the company’s shares. Shenzhen Maoye and its concerted action () Co., Ltd. reduced their holdings by a total of 18,804,900 shares, with a reduction ratio of 1.078%.
Huajian Group made LP and invested 480 million yuan.
On August 16th, the investment community reported that East China Construction Group Co., Ltd. () announced that the company intends to use its own funds to subscribe for 480 million yuan to participate in the investment of high-quality private equity partnership enterprises in Shanghai Park as a limited partner.
It is reported that the target scale of the fund is planned to be RMB 3.481 billion, with Shanghai Linfang Equity Investment Management Co., Ltd. as the fund manager, focusing on investing in the infrastructure of the park, with industrial workshops, R&D, innovative design and pilot platforms, warehousing and logistics, business incubators and industrial accelerators, and affordable rental housing.
Huajian Group is a high-tech listed enterprise relying on Pioneer Technology. The group is positioned as an integrated service provider with engineering design consulting as the core and providing high-quality comprehensive solutions for urban construction. It owns more than 20 molecular companies and professional institutions, including East China Architectural Design and Research Institute, Shanghai Architectural Design and Research Institute, East China Urban Architectural Design and Research Institute and Shanghai Hydraulic Engineering Design and Research Institute.
Fangda Special Steel plans to set up a wholly-owned subsidiary with a registered capital of 30 million yuan.
() Announce that in order to effectively improve the company’s management level and realize the effective allocation of resources, according to the needs of the company’s business development, the company established a wholly-owned subsidiary Ningbo Changli International Trade Co., Ltd. with its own funds (subject to the approval of the industrial and commercial department) with a registered capital of RMB 30 million. The establishment of Ningbo Changli is conducive to meeting the needs of the company’s business development, optimizing the company’s resource allocation and improving the company’s management level.
Hua ding shares’s 47,816,600 restricted shares will be listed and circulated on August 22nd.
() Announced that the number of restricted shares listed and circulated this time was 47,816,600 shares, accounting for 4.19% of the company’s total share capital, and the listing and circulation date was August 22, 2022.
Southern Media sent 3.3 yuan date of record for every 10 shares on August 22nd.
() It is announced that the company will distribute the annual rights and interests in 2021, and distribute a cash dividend of 3.30 yuan (including tax) to all shareholders for every 10 shares, with date of record on August 22nd.
Tianchen shares plan to pay 0.055 yuan per share in cash dividend on August 23rd.
() Announcement, the company plans to distribute a cash dividend of 0.055 yuan (including tax) per share in the annual equity distribution in 2021, and the cash dividend distribution date is August 23, 2022.
Tianchen co., ltd. completed the investment in Shanghai Chenhao architectural decoration engineering company.
Tianchen shares announced that the company set up a wholly-owned subsidiary "Shanghai Chenhao Building Decoration Engineering Co., Ltd." with its own funds of RMB 5 million. Shanghai Chenhao Building Decoration Engineering Co., Ltd. has completed the relevant industrial and commercial registration procedures and obtained the Business License issued by Shanghai Baoshan District Market Supervision Administration.
Anhui Zhidao, the shareholder of Shengxiang Bio, intends to reduce its shareholding by no more than 2%.
Shengxiang Bio announced that due to its own capital needs, Anhui Zhidao intends to reduce its holdings of Shengxiang () by no more than 11,769,200 shares through centralized bidding, accounting for 2.00% of the company’s total share capital, which will be implemented within 6 months after 15 trading days from the date of the reduction plan, and the total number of shares reduced within 90 consecutive days will not exceed 1% of the company’s total shares.
Anhui Zhidao, the shareholder of Shengxiang Bio, intends to reduce its shareholding by no more than 2%.
Shengxiang Bio announced that due to its own capital demand, Anhui Zhidao intends to reduce its holdings of Shengxiang Bio by no more than 11,769,200 shares through centralized bidding transactions, accounting for 2.00% of the company’s total share capital, which will be implemented within 6 months after 15 trading days from the date of release of the reduction plan, and the total number of shares reduced within 90 consecutive days will not exceed 1% of the company’s total shares.
The application for clinical trial of another antiviral drug in Kexing Pharmaceutical was accepted.
On August 15th, Kexing Pharmaceutical announced that its application for clinical trial of "human interferon α2b spray" had been accepted by National Medical Products Administration.
This is the third clinical trial application for antiviral drugs disclosed by Kexing Pharmaceutical for three months in a row. The first two are Shen 26, a small molecule oral drug against COVID-19 (disclosed on July 17, and approved), and α2b effervescent capsules, which are also human interferon (disclosed on June 20, and accepted).
Kexing Pharmaceutical Co., Ltd. is an innovative international biopharmaceutical enterprise mainly engaged in the integration of R&D, production and sales of recombinant protein drugs and microecological agents. The company has been deeply involved in the field of antivirus for more than 20 years and achieved fruitful results. Its wholly-owned subsidiary, Shenzhen Kexing, is the first batch of the first industrialization base of China’s 863 Program achievements, and successfully developed the first domestic biological agent interferon α 1b-siroqin. With the entry of two products, SHEN26, a small molecule oral drug against COVID-19, and human interferon α2b, the pipeline layout of antiviral products of Kexing Pharmaceutical has become more complete and rich.
It is understood that interferon can be described as a "sword" in the field of antivirus. It is a cytokine released by cells stimulated by virus infection. It is a soluble protein with multiple functions produced by monocytes and lymphocytes. It is a key effector molecule of innate and adaptive immunity, with broad-spectrum antiviral activity and immunomodulation, and is an important part of the body’s defense system. Interferon induces cells to produce a variety of antiviral proteins by binding to cell surface receptors, and inhibits virus replication in cells. At the same time, the specific cytotoxicity of macrophages and lymphocytes on target cells is enhanced by regulating immune function, which can effectively curb the occurrence of virus invasion and infection, enhance the activity of natural killer cells, inhibit the growth of tumor cells and eliminate early malignant cells.
The human interferon α2b spray declared this time is two kinds of improved new drugs independently developed by Kexing Pharmaceutical. It optimizes the dosage form and administration route of the listed drugs, and increases the drug concentration in the focus by targeted local administration. It is convenient to use and carry, and has good patient compliance, which has obvious clinical advantages. The indication of the company’s human interferon α2b spray is to treat primary or recurrent skin herpes simplex (oral herpes and genital herpes) caused by virus.
Kexing Pharmaceutical said that the research and development of the company’s human interferon α2b spray will help optimize the company’s product structure, enrich the product pipeline, enhance the company’s overall research and development capabilities and enhance the company’s long-term profitability. (Tan Pengpeng)
Xiamen Tungsten Industry and Northern Rare Earth signed a strategic cooperation framework agreement.
() announced that the Company and () signed this Agreement in Baotou City, Inner Mongolia Autonomous Region on August 16th, 2022. The two sides established a strategic partnership with each other. The two sides agreed that mutual benefit and win-win will be achieved through the coordinated development plan in the field of cooperation, so as to jointly form development advantages and promote all parties and their affiliated companies to become bigger and stronger. The two sides intend to carry out extensive cooperation in rare earth products, technical cooperation, equity, industrial operation, management, personnel training and exchanges.
Xiamen Tungsten Industry and Northern Rare Earth signed a strategic cooperation framework agreement.
Xiamen Tungsten Industry announced that the company and Northern Rare Earth signed this Agreement in Baotou City, Inner Mongolia Autonomous Region on August 16, 2022. The two sides established a strategic partnership with each other. The two sides agreed that mutual benefit and win-win will be achieved through the coordinated development plan in the field of cooperation, so as to jointly form development advantages and promote all parties and their affiliated companies to become bigger and stronger. The two sides intend to carry out extensive cooperation in rare earth products, technical cooperation, equity, industrial operation, management, personnel training and exchanges.
70 million shares of the company held by the controlling shareholder of Blu-ray Development will be auctioned by the judiciary.
() Announcement, the company received a notice from the controlling shareholder Blu-ray Group that some of its shares will be auctioned in September 2022. As of August 15, 2022, Blu-ray Investment Holding Group Co., Ltd. (hereinafter referred to as "Blu-ray Group"), the controlling shareholder of the company, held 1.048 billion shares of the company, accounting for 34.53% of the company’s total share capital. The shares auctioned by the judiciary this time are 70 million shares held by Blu-ray Group, accounting for 2.31% of the company’s total share capital.
Blu-ray development: The relevant resources and technical personnel of the invested photovoltaic company have not been equipped.
Blu-ray Development announced the change on the evening of August 16th. Recently, some media reported that Blu-ray Development cooperated with Guangdong Ouhao Group Co., Ltd. to establish Chengdu Oulan Photovoltaic Co., Ltd. to carry out photovoltaic projects. Chengdu Oulan Photovoltaic Co., Ltd. is a recently registered company with a registered capital of 100 million yuan, and its shareholding ratio is 30% (non-holding), which has not been paid in. At present, relevant resources and technical personnel have not been equipped, and there are no cooperation projects, so there are uncertainties in the follow-up. Up to now, the company’s debt restructuring plan is still being drafted, and there is no substantial progress.
Two-panel blue light development: at present, photovoltaic related resources and technical personnel have not been equipped, and there are no cooperation projects.
Blu-ray Development announced a change announcement. Recently, some media reported that Blu-ray Development cooperated with Guangdong Ouhao Group Co., Ltd. to establish Chengdu Oulan Photovoltaic Co., Ltd. to carry out photovoltaic projects. Chengdu Oulan Photovoltaic Co., Ltd. is a recently registered company with a registered capital of 100 million yuan, and its shareholding ratio is 30% (non-holding), which has not been paid in. At present, relevant resources and technical personnel have not been equipped, and there are no cooperation projects, so there are uncertainties in the follow-up.
The cumulative reduction ratio of Lan Jian intelligent shareholder Jinan Venture Capital reached 1.03%, and the reduction amount was more than half.
Lan Jian Intelligent announced that on August 16, 2022, the company received a letter of notification from the shareholder Jinan Technology Venture Capital Group Co., Ltd. (hereinafter referred to as "Jinan Venture Capital"). From July 29, 2022 to August 16, 2022, Jinan Venture Capital reduced its holdings of the company’s shares by centralized bidding, accounting for 749,500 shares, accounting for 1.03% of the company’s total shares. The number of this reduction plan has exceeded half, and the reduction plan has not yet been implemented.
Parker New Materials: The application for non-public offering of shares was approved by CSRC.
() Announcement: The company received a reply from the China Securities Regulatory Commission, approving the company to issue no more than 21.6 million new shares in a non-public manner.
Shengxiang Bio: Zhidao Investment intends to reduce its shareholding by no more than 2%.
Shengxiang Bio announced on the evening of August 16 that Anhui Zhidao Investment Co., Ltd., a shareholder holding 5.1% of the company’s shares, intends to reduce its shareholding by no more than 2%.
Donghu High-tech: The subsidiaries jointly won the bid for the PPP development and construction project in the industrial park.
Donghu High-tech announced that the consortium led by Hubei Luqiao, a wholly-owned subsidiary, won the bid for the PPP development and construction project of Dangyang Economic Development Zone Industrial Park, with a total investment of 1.867 billion yuan.
Dongfang Huanyu: Li Weiwei, the actual controller, intends to reduce his shareholding by no more than 0.26%.
Released on August 16th-Dongfang Huanyu announced that the company received the Letter of Notice on Share Reduction Plan issued by Li Weiwei, the actual controller, director and deputy general manager, on August 16th, 2022, and that Li Weiwei intends to reduce the shares of the company he holds by centralized competitive bidding within six months after fifteen trading days from the date of disclosure of this announcement, with a total of no more than 500,000 shares, accounting for no more than 0.26% of the total share capital of the company.
Trial production of Wansheng Dawei technical transformation project of Wansheng Co., Ltd.
Wansheng Co., Ltd. announced that Wansheng Dawei, a wholly-owned subsidiary, has completed the construction of the main body of the project and the installation and commissioning of equipment for the technical transformation project of fatty amine and its derivative products (including electronic trioctylamine, tertiary alkyl amine and quaternary ammonium salt) with an annual output of 27,000 tons. After the trial production plan has been reviewed and approved by experts and filed by relevant competent authorities, it meets the trial production conditions and has officially entered the trial production stage.
Shareholders of Guanshi Technology intend to reduce their holdings by no more than 6% in total.
Guanshi Technology announced that the shareholders of the company, Xianghe Yongyuan, Yongjie Investment, Yongji Huachuang and Haoxin Investment, intend to reduce their shares in the company through centralized bidding and block trading, with a total reduction of no more than 4,385,973 shares, accounting for 6% of the total share capital of the company. The main body of the above reduction is a concerted action.
Bank of Nanjing: The acquisition of Suning Xiaojin’s equity was approved by the regulatory authorities, and the shareholding ratio increased from 15% to 56%.
On August 16th, Bank of Nanjing announced that Xiaojin had recently received the Reply of China Bank on the Change of Equity of Suning Co., Ltd. from the Insurance Regulatory Commission, and agreed that the company would accept 36% equity of Suning Xiaojin held by Suning.cn Group Co., Ltd. and 5% equity of Suning Xiaojin held by Jiangsu Yanghe Winery Co., Ltd. After the completion of this equity change, the company’s shareholding in Suning Xiaojin will increase from 15% to 56%.
It is understood that on January 13, 2022, the Ninth Meeting of the Ninth Board of Directors of Bank of Nanjing reviewed and approved the Proposal on Acquisition of Controlling Shares of Participating Financial Institutions, and started the acquisition of equity of Suning Xiaojin. On March 4, 2022, the signing of the 41% equity acquisition agreement of Suning Xiaojin was completed.
Zhongheng Group obtained the drug registration certificate and the notice of approval for the listing application of chemical raw materials.
() It was announced that Chongqing () Co., Ltd. (hereinafter referred to as "Laimei Pharmaceutical"), the holding subsidiary of the company, received the Drug Registration Certificate of esmomeprazole magnesium enteric-coated capsules of 20mg and 40mg approved and issued by National Medical Products Administration, and Chongqing Laimei Longyu Pharmaceutical Co., Ltd. (hereinafter referred to as "Laimei Longyu"), the holding grandson of the company, received the Notice of Approval for the Listing of Esomeprazole magnesium API approved and issued by National Medical Products Administration.
This time, Laimei Pharmaceutical and Laimei Longyu obtained the Drug Registration Certificate of Esomeprazole Magnesium Enteric-coated Capsules (specifications: 20mg and 40mg) and the Notice of Approval for the Marketing Application of Esomeprazole Magnesium Bulk Drug, which is conducive to further enriching the company’s product line and increasing the company’s market share of digestive tract drugs.
From January to July, China Chemical signed a total of 182.939 billion yuan of new contracts, a year-on-year increase of 29.56%.
() Announced that from January to July, 2022, the company realized an accumulated operating income of 88.69 billion yuan, a year-on-year increase of 35.52%; The cumulative amount of newly signed contracts was 182.939 billion yuan, a year-on-year increase of 29.56%.
China Chemistry: In the first seven months, the revenue reached 88.69 billion yuan, a year-on-year increase of 35.52%.
China Chemical announced on the evening of August 16 that from January to July, the company realized an accumulated operating income of 88.69 billion yuan, a year-on-year increase of 35.52%; The cumulative amount of newly signed contracts was 182.939 billion yuan, a year-on-year increase of 29.56%.
Shenzhen Venture Capital, a shareholder of Pumen Technology, and its related parties reduced their holdings by 4 million shares to 5.55%.
Pumen Technology announced that the company’s shareholder Shenzhen Innovation Investment Group Co., Ltd. ("Shenzhen Venture Capital") and its related parties Shenzhen Hongtu Peacock Venture Capital Co., Ltd., Shenzhen Talent Innovation Venture No.1 Equity Investment Fund (Limited Partnership), Jiangsu Hongtu Software Venture Capital Co., Ltd., Guangdong Hongtu Venture Capital Co., Ltd. and Dongguan Hongtu Venture Capital Co., Ltd. reduced their holdings by 4,002,200 shares from February 17 to August 16, 2022, accounting for 0.95% of the company’s total share capital.
The final success rate of online issuance of Xuantai Medicine after callback was 0.0337%.
Xuantai Pharmaceutical announced that after the callback mechanism was started, the final number of shares issued offline was 30,151,000 shares, accounting for 70.00% of the number issued after deducting the number of strategic placements, and the final number of shares issued online was 12,922,000 shares, accounting for 30.00% of the number issued after deducting the number of strategic placements. After the callback mechanism is started, the final winning rate of online issuance is 0.03366050%.
Grasping the opportunity of "new infrastructure", Sichuan Road and Bridge strives to create a new field of "intelligent manufacturing"
Recently, () announced that the main purpose of strategic cooperation with Sichuan Energy Investment Group Co., Ltd. (hereinafter referred to as "Nengtou Group") and () Co., Ltd. (hereinafter referred to as "BYD") is to better empower the company to be digital and green and low-carbon. "Listed companies are committed to digital transformation, and Nengtou Group and BYD have important strategic resources for the transformation and upgrading of the transportation infrastructure construction business undertaken by Sichuan Luqiao through technology empowerment".
It is reported that at present, Sichuan Road and Bridge has cooperated with Chinese Academy of Sciences to carry out intelligent driving research in the field of construction machinery, and its core technology has been successfully applied to the self-developed automatic intelligent loader, and the construction equipment has been tested and put into trial operation in the construction scene of Sichuan Road and Bridge. In the future, Sichuan Luqiao will deepen cooperation with strategic partners such as BYD and Nengtou Group in the research field to further promote the digitalization and green low-carbon transformation of enterprises.
Respond to the call of national intelligent construction and comprehensively lay out green and low-carbon construction equipment.
According to Lu Wei, chief engineer of Sichuan Road and Bridge, as early as July 2020, 13 departments including the Ministry of Housing and Urban-Rural Development jointly issued the Guiding Opinions on Promoting the Coordinated Development of Intelligent Construction and Building Industrialization. In September, 2021, the State Council, the Central Committee of the Communist Party of China issued the Opinions on Completely, Accurately and Comprehensively Implementing the New Development Concept and Doing a Good Job of Carbon Neutralization in peak carbon dioxide emissions. The introduction of these policies are all important instructions made by the state for energy conservation, emission reduction and high-quality development of traditional construction machinery and construction industry.
This also means that the construction machinery and construction industry, as traditional high-energy enterprises, must actively upgrade their industrial intelligence and use cleaner and more environmentally friendly energy in order to stay ahead of the times. At the same time, relevant information also shows that at present, the bidding standards of road and bridge construction owners in many developed areas abroad have gradually upgraded from economically applicable requirements to the requirements of carbon neutrality, carbon emission and sustainable development, and the external ability of traditional construction technology to obtain orders is gradually weakening.
From this point of view, whether it is the business layout planning of Sichuan Road and Bridge as an advanced domestic construction unit "going out" or the strategic guidance of domestic macro-planning, actively deploying intelligent manufacturing has become the only way for Sichuan Road and Bridge to transform and upgrade and move towards high-quality development.
In terms of actual progress, the data show that at present, Sichuan Road and Bridge has established a low-carbon intelligent innovation laboratory of Shudao Group with BYD and many large domestic machinery and equipment manufacturers, which is committed to solving technical problems such as standardization of charging and replacing battery interfaces, battery modularization and charging and replacing facilities for intelligent road openers, road rollers, construction heavy commercial vehicles and construction machinery vehicles. In addition, in the field of "Three Electricity" (battery, motor and circuit system) of construction machinery, BYD has also cooperated with Sichuan Road and Bridge to complement each other’s advantages and worked together to provide a more economical, durable and suitable package of construction services for the construction site, further enhancing the core competitiveness of China Construction and jointly promoting the innovation and commercial application of related technologies in the field of transportation infrastructure construction.
Embrace the core technology and promote the improvement of construction energy efficiency
At the same time, Wang Yue, general manager of Sichuan Intelligent Construction Technology Co., Ltd. further introduced that through years of joint research with the Chinese Academy of Sciences, Sichuan Road and Bridge now has the leading artificial intelligence driving system for construction machinery in China.
"Sichuan Road and Bridge has invested two things through the artificial intelligence driving system and a large number of equipment in engineering construction scenes, forming supporting intellectual property rights for information intelligent construction. At present, the fully-automatic loader applying the company’s independent intellectual property rights has been put into trial use. In the future, road and bridge planning will cooperate with strategic parties in the production and leasing of fully-automatic loaders, which may become another new profit growth engine of Sichuan Road and Bridge. "
It is worth mentioning that in addition to in-depth research and development of artificial intelligence digital production equipment, Sichuan Road and Bridge has completed research and development and put into trial use, as well as intelligent construction beam factory. According to reports, Sichuan Luqiao 2.0 Beam Factory, which has an intelligent factory line, has nearly doubled its production efficiency compared with the traditional one, and its production quality and production safety guarantee have also been improved and strengthened. The demand for workers in the production line has also dropped from 100 to 80.
At the same time, Sichuan Road and Bridge is also upgrading its intelligent manufacturing in the fields of unmanned pavement construction and intelligent tunnel construction. Taking the intelligent tunnel construction as an example, in related operations, the company not only seamlessly transformed and connected the construction equipment on the AI platform through each process, but also changed the traditional construction norms and made technological innovations in the blasting mode of blasting explosives, which solved the problem of difficult control of initiation in fully automatic scenes.
"The company’s research on industrial upgrading is to find an industrial scene that is more suitable for intelligent manufacturing in the whole industrial chain of new infrastructure. And this kind of technological innovation is not simply digital and intelligent machinery. The core connotation of the company’s industrial upgrading is to study the technical scheme and reconstruct the construction production from the bottom logic, in order to improve the production energy efficiency and meet the requirements of energy conservation and emission reduction. "
Complementary advantages, the frontier of production, investment and research work together to overcome technical difficulties
It is foreseeable that with the advantages of multiple construction scenes of Sichuan Road and Bridge, the existing technical reserves and the heavy support of BYD’s core technologies and production capacity, such as batteries, motors, electronic control systems, and car-level chips, the two partners will surely overcome all links involving intelligent manufacturing in the future, and gradually carry out pilot and promotion. "From enterprise standards to local standards, and then complete the old and new transformation and technological change of the new infrastructure industry".
However, in the process of upgrading the whole industry, the company also said that there are still some technical difficulties that have not been overcome, such as the replacement of new energy lithium batteries, the energy storage of mechanical engineering power, and the application of artificial intelligence in pavement construction.
In view of the technical difficulties that have been overcome in the current research and development, the company actively carries out technical reserves and strategic layout, with a view to the transformation of core technologies in the future: in terms of battery energy storage, the company established a mining investment and development company to reserve mineral resources and make resource reserves for the battery processing of the company’s construction equipment.
From the layout of intelligent manufacturing to the introduction of strategic partners, the successful incubation of intelligent beam factory and the successful trial of fully automatic road loader, Sichuan Luqiao has gradually transformed and upgraded from a traditional large-scale infrastructure company with multiple construction qualifications to a new intelligent manufacturing infrastructure company with core intellectual property rights. In the future, after further deepening cooperation with BYD and Nengtou Group, we look forward to the next breakthrough in the technical difficulties of intelligent construction.
Vast depth will be listed on the Shanghai Stock Exchange in science and technology innovation board on August 18th.
Vast depth announcement, the company’s stock will be listed in science and technology innovation board on August 18th, 2022.
Shengxiang Bio-shareholders intend to reduce their holdings by no more than 2%.
Shengxiang Bio announced that Anhui Zhidao, a shareholder holding 5.10% shares, intends to reduce the company’s shares by no more than 2% of the company’s total share capital through centralized bidding transactions.
() 4.6136 yuan will be distributed for every 10 shares in 2021, and date of record will be August 22nd.
Haier Zhijia announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 6,224,810,900 shares, a cash dividend of 4.61 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 2.872 billion yuan will be distributed, accounting for 21.98% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is August 22nd, and the ex-dividend date is August 23rd.
According to the 2021 annual performance report released by Haier Zhijia, the company’s operating income was 227.556 billion yuan, an increase of 8.5% year-on-year; The net profit attributable to shareholders of listed companies was 13.067 billion yuan, a year-on-year increase of 47.1%; The basic earnings per share was 1.41 yuan, compared with 1.34 yuan in the same period last year.
Haier Zhijia Co., Ltd. is an electrical appliance company. The company is mainly engaged in the production and operation of refrigerators, air conditioners, electric freezers, washing machines, water heaters, dishwashers, gas stoves and other household appliances and related products, as well as the commercial circulation business in gooday.
Up to now, the company has accumulated more than 53,000 patent applications around the world, including more than 33,000 invention patents, accounting for more than 60%, ranking first in China’s home appliance industry, reflecting the leading patent quality; There are more than 11,000 overseas invention patents, covering 28 countries, and it is the China household appliance enterprise with the most overseas patents; Accumulated 9 national patent gold medals, ranking first in the domestic industry; "National Science and Technology Progress Award" is the highest honor in China’s scientific and technological circles, and Haier has won 15 awards, which is the home appliance enterprise that has won the most awards, accounting for more than half of the industry. It has won 3 "China Excellent Industrial Design Gold Awards" by the Ministry of Industry and Information Technology, and is the only enterprise that has won the "National Industrial Design Gold Award" for three consecutive years; Accumulated 3 international design gold medals and 194 design awards (including the above 3 gold medals).
(Source: Straight Flush iFinD)
In 2021, Kangxinuo sent 8 yuan date of record for every 10 shares on August 22nd.
Kangxinuo announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 114,279,000 shares, a cash dividend of 8.00 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 91,423,200 yuan will be distributed, accounting for 4.78% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is August 22nd, and the ex-dividend date is August 23rd.
According to the 2021 annual performance report released by Kangxinuo, the company’s operating income was 4.300 billion yuan, a year-on-year increase of 17,174.82%; The net profit attributable to shareholders of listed companies was 1.914 billion yuan, turning losses into profits year-on-year, compared with-397 million yuan in the same period last year; The basic earnings per share was 7.74 yuan, compared with -1.72 yuan in the same period last year.
The main business of Kangxinuo Biological Co., Ltd. is research and development, production and commercialization of innovative vaccines that meet China and international standards. The company’s main products are Ebola virus disease vaccine, meningitis vaccine, DTP vaccine, pneumonia vaccine, tuberculosis vaccine, herpes zoster vaccine, COVID-19 vaccine, adenovirus vaccine and polio vaccine. The company has won many honors, such as "Tianjin Gazelle Enterprise Outstanding Innovation Award", "China’s Most Growing Scientific and Innovative Pharmaceutical Enterprise" and "Tianjin Key Laboratory of Respiratory Bacterial Recombination and Combined Vaccine Enterprise".
(Source: Straight Flush iFinD)
Ai Ai Seiko will pay 1.64 yuan for every 10 shares in 2021, and date of record will be August 24th.
Aiai Seiko announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 130,673,200 shares, a cash dividend of 1.64 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 21,430,400 yuan will be distributed, accounting for 62.9% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is August 24th, and the ex-dividend date is August 25th.
According to the 2021 annual performance report released by Ai Ai Seiko, the company’s operating income was 252 million yuan, a year-on-year increase of 30.04%; The net profit attributable to shareholders of listed companies was 34.073 million yuan, an increase of 11.48% year-on-year; The basic earnings per share was 0.26 yuan, compared with 0.23 yuan in the same period last year.
Aiai Precision Industrial Conveying System (Shanghai) Co., Ltd. is mainly engaged in the research and development, production and sales of light conveyor belts. The main products are light industrial belts made of ordinary polymer materials and precision industrial belts made of environment-friendly polymer materials.
(Source: Straight Flush iFinD)
Mubang Hi-Tech plans to invest 4.8 billion yuan to build a 10GW TOPCON photovoltaic cell production base project.
() Announced that the company signed the Strategic Cooperation Framework Agreement with the People’s Government of Echeng District. Both parties are willing to make full use of their respective resource advantages, arrange about 500 mu of project land in the People’s Government Park of Echeng District, and build a 10GW TOPCON photovoltaic cell production base project. The investment scale of the project is estimated to be 4.8 billion yuan.
At present, the company is not engaged in photovoltaic cell business, nor has TOPCON photovoltaic cell production technology reserve, nor has TOPCON cell talent team, and is actively contacting to introduce talents in related fields, which may lead to the risk that the introduction of talents is not up to expectations.
Mubang Hi-Tech terminated the construction of 8GW TOPCON photovoltaic cell production project.
Mubang Hi-Tech announced that on June 2, 2022, the company signed the Investment Strategic Cooperation Framework Agreement with the Anyi County People’s Government, and arranged about 300 mu of land for the project within the industrial park to build an 8GW TOPCON photovoltaic cell production project.
After the signing of the Framework Agreement, the company and the Anyi County People’s Government fully communicated and exchanged views on the project promotion of this cooperation, and no specific cooperation agreement has been formed so far. Through friendly negotiation, the company decided to terminate the Framework Agreement signed with the Anyi County People’s Government.
Pingxiang Jingyi, the shareholder of Platinum, intends to reduce its shareholding by no more than 2.8%.
Platinum announced that Pingxiang Jingyi, a shareholder holding 11.23% of shares, intends to reduce its holdings by no more than 2.8% of the company’s total share capital through centralized bidding and block trading.
Mubang Hi-Tech: It is planned to build a 10GW TOPCON photovoltaic cell production base project.
Mubang Hi-Tech announced that the company has signed the Strategic Cooperation Framework Agreement with the government of Echeng District, and plans to arrange about 500 mu of project land in the government park of Echeng District to build a 10GW TOPCON photovoltaic cell production base project. The investment scale of the project is estimated to be 4.8 billion yuan.
On the same day, the company announced that on June 2, 2022, the company signed the Framework Agreement on Investment Strategic Cooperation with Anyi County Government, and planned to arrange about 300 mu of land for the project within the industrial park to build an 8GWTOPCON photovoltaic cell production project. After the signing of the Framework Agreement, the company and Anyi county government have fully communicated and exchanged views on the promotion of this cooperation project, and no specific cooperation agreement has been formed so far. Through friendly negotiation, the company decided to terminate the Framework Agreement signed with Anyi County Government.
CDH Investment, the major shareholder of Xinneng Technology, has reduced its shareholding by 1%.
() Announcement: from July 18, 2022 to August 16, 2022, Dinghui Investment, a shareholder holding more than 5% of the company’s shares, has reduced its holdings of 5 million shares through centralized bidding, accounting for 1.0000% of the company’s total share capital. The planned reduction of shares through this centralized bidding has exceeded half.
Mubang Hi-Tech: It is planned to invest 4.8 billion yuan to build a 10GW TOPCON photovoltaic cell production base project.
Mubang Hi-Tech announced on the evening of August 16th that the company signed the Strategic Cooperation Framework Agreement with the government of Echeng District. Both parties are willing to arrange about 500 mu of land for the project in the government park of Echeng District to build a 10GW TOPCON photovoltaic cell production base project. The investment scale of the project is estimated to be 4.8 billion yuan. In addition, the company terminated the framework agreement signed with Anyi county government for the construction of 8GW TOPCON photovoltaic cell production project.
Bolite: Pingxiang Jingyi intends to reduce its shareholding by no more than 2.8%.
On the evening of August 16th, Platinum announced that Pingxiang Jingyi Business Information Consulting Partnership (Limited Partnership) (hereinafter referred to as "Pingxiang Jingyi"), a shareholder holding 11.23% of the company’s shares, intends to reduce its holdings by no more than 2.8%.
Platinum shareholders intend to reduce their holdings by no more than 2.8%.
Platinum announced that Pingxiang Jingyi, a shareholder holding 11.23%, plans to reduce the company’s shares by no more than 2.8% of the company’s total share capital.
Lianglianban Guangan Aizhong: At present, the company’s production and operation activities are normal.
The financial sector announced on August 16th that the company’s current production and operation activities are normal. Recently, the power supply in Sichuan is facing a severe situation, and the company has started the first-level power supply control measures. The company’s power supply pressure is obvious, but the internal production and operation order is normal, and the company’s operating performance has not been significantly affected.
Tianchen shares will be paid 0.55 yuan for every 10 shares in 2021, and date of record will be August 22nd.
Tianchen Co., Ltd. announced that the implementation plan of the company’s annual equity distribution in 2021 is as follows: based on the total share capital of 686,677,100 shares, a cash dividend of 0.55 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 37,767,200 yuan will be distributed, accounting for 30.69% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is August 22nd, and the ex-dividend date is August 23rd.
According to the 2021 annual performance report released by Tianzhu Co., Ltd., the company’s operating income was 41.8176 million yuan, a year-on-year increase of 13.37%; The net profit attributable to shareholders of listed companies was 123 million yuan, a year-on-year increase of 16.84%; The basic earnings per share was 0.18 yuan, compared with 0.15 yuan in the same period last year.
Shanghai Tianchen Co., Ltd. mainly engages in taxi operation, property leasing and property management. Mainly including taxi operation and property leasing.
(Source: Straight Flush iFinD)
Southern Media will send 3.3 yuan date of record for every 10 shares in 2021 as August 22nd.
Southern Media announced that the company’s annual equity distribution implementation plan for 2021 is as follows: based on the total share capital of 881,970,100 shares, a cash dividend of 3.30 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 291 million yuan will be distributed, accounting for 36.01% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is August 22nd, and the ex-dividend date is August 23rd.
According to the 2021 annual performance report released by Southern Media, the company’s operating income was 7.598 billion yuan, a year-on-year increase of 10.17%; The net profit attributable to shareholders of listed companies was 808 million yuan, a year-on-year increase of 6.3%; The basic earnings per share was 0.90 yuan, compared with 0.85 yuan in the same period last year.
The main business of Southern Publishing Media Co., Ltd. is book publishing, printing and material supply, newspapers and new media. The company’s main products are teaching materials, teaching AIDS, general books, audio-visual products, stationery and newspaper media.
Nine books, such as China’s Great Logic of Reform, China Bridge: The Dream of Hong Kong-Zhuhai-Macao Bridge, Far Sunflower Field, and two audio-visual products, such as Forty Years of Fengyun and Hong Kong-Zhuhai-Macao Bridge, were awarded the "Five One Projects" in the 11th Guangdong Province. By the end of June 2019, the number of commercial downloads of "Time Finance" APP reached 15 million/person, with 500,000 registered users. It won the "Best New Media Platform" award in the list of new economic innovation forces in China in 2019, and ranked fourth in the list of financial apps in Internet Weekly of Chinese Academy of Sciences in the first half of 2019.
(Source: Straight Flush iFinD)
Mubang Hi-Tech: It is planned to invest 4.8 billion yuan to build a 10GW TOPCON photovoltaic cell production base project.
The financial sector announced on August 16th that Mubang Hi-Tech had signed the Strategic Cooperation Framework Agreement with the People’s Government of Echeng District. Both parties are willing to make full use of their respective resource advantages, arrange about 500 mu of project land in the people’s government park of Echeng District, and build a 10GW TOPCON photovoltaic cell production base project. The investment scale of the project is estimated to be 4.8 billion yuan. On the same day, it was announced that the company terminated the framework agreement signed with the Anyi County People’s Government for the construction of 8GW TOPCON photovoltaic cell production project.
Guang ‘an Aizhong’s current production and operation activities are normal.
Guang ‘an Aizhong announced that the deviation of the closing price of the company’s shares in three consecutive trading days on August 12, August 15 and August 16, 2022 was more than 20%, which was an abnormal fluctuation of stock trading according to the relevant provisions of the Trading Rules of Shanghai Stock Exchange.
The company’s current production and operation activities are normal. Recently, the power supply in Sichuan is facing a severe situation, and the company has started the first-level power supply control measures. The company’s power supply pressure is obvious, but the internal production and operation order is normal, and the company’s operating performance has not been significantly affected.
Further focus on the main business Xingfa Group intends to spin off its holding subsidiary Xingfu Electronics to list in science and technology innovation board.
Xingfa Group announced on the evening of August 16 that the company received a notice from its holding subsidiary Xingfu Electronics on August 16, and Xingfu Electronics registered the initial public offering counseling in Hubei Securities Regulatory Bureau on August 15. On the same day, Hubei Securities Regulatory Bureau officially issued a confirmation letter for counseling registration, and the counseling institution was TF Securities.
It is understood that Xingfa Group intends to spin off Xingfu Electronics to the Shanghai Stock Exchange for listing in science and technology innovation board. After the completion of this spin-off, the ownership structure of Xingfa Group will not change, and it will still maintain its control over Xingfu Electronics.
Through this spin-off, Xingfa Group will further focus on the production and sales of fine phosphorus chemical products such as phosphate rock and phosphate, glyphosate, silicone products, chlor-alkali, dimethyl sulfoxide and fertilizer products, and the trade business of related chemical products; Xingfu Electronics will become an independent electronic chemicals business listing platform under Xingfa Group. The spin-off and listing is conducive to further enhancing the cohesion of the core personnel of Xingfu Electronics, enhancing the brand awareness and social influence of Xingfu Electronics, strengthening the competitive position and advantages of Xingfu Electronics in the field of electronic chemicals, enhancing the R&D investment of Xingfu Electronics in core and cutting-edge technologies and products, maintaining the vitality of business innovation, enhancing the market development ability and promoting its healthy and sustainable development.
This spin-off can only be implemented after meeting a number of conditions, including but not limited to obtaining the formal approval of the company’s shareholders’ meeting and fulfilling the corresponding procedures of Shanghai Stock Exchange and China Securities Regulatory Commission. There are uncertainties about whether this spin-off can be approved or not, and when it will finally be approved or approved. (Cheng Wei)
Further focus on the main business Xingfa Group intends to spin off its holding subsidiary Xingfu Electronics to list in science and technology innovation board.
Xingfa Group announced on the evening of August 16 that the company received a notice from its holding subsidiary Xingfu Electronics on August 16, and Xingfu Electronics registered the initial public offering counseling in Hubei Securities Regulatory Bureau on August 15. On the same day, Hubei Securities Regulatory Bureau officially issued a confirmation letter for counseling registration, and the counseling institution was TF Securities.
It is understood that Xingfa Group intends to spin off Xingfu Electronics to the Shanghai Stock Exchange for listing in science and technology innovation board. After the completion of this spin-off, the ownership structure of Xingfa Group will not change, and it will still maintain its control over Xingfu Electronics.
Through this spin-off, Xingfa Group will further focus on the production and sales of fine phosphorus chemical products such as phosphate rock and phosphate, glyphosate, silicone products, chlor-alkali, dimethyl sulfoxide and fertilizer products, and the trade business of related chemical products; Xingfu Electronics will become an independent electronic chemicals business listing platform under Xingfa Group. The spin-off and listing is conducive to further enhancing the cohesion of the core personnel of Xingfu Electronics, enhancing the brand awareness and social influence of Xingfu Electronics, strengthening the competitive position and advantages of Xingfu Electronics in the field of electronic chemicals, enhancing the R&D investment of Xingfu Electronics in core and cutting-edge technologies and products, maintaining the vitality of business innovation, enhancing the market development ability and promoting its healthy and sustainable development.
This spin-off can only be implemented after meeting a number of conditions, including but not limited to obtaining the formal approval of the company’s shareholders’ meeting and fulfilling the corresponding procedures of Shanghai Stock Exchange and China Securities Regulatory Commission. There are uncertainties about whether this spin-off can be approved or not, and when it will finally be approved or approved. (Cheng Wei)
Mubang Hi-Tech plans to invest 4.8 billion yuan to build a photovoltaic cell production base project and terminate the project signed with Anyi County.
Mubang Hi-Tech announced on the evening of August 16th that it had signed the Strategic Cooperation Framework Agreement with the people’s government of Echeng District. Both parties are willing to make full use of their respective resource advantages, arrange about 500 mu of project land in the people’s government park of Echeng District, and build a 10GW TOPCON photovoltaic cell production base project. The investment scale of the project is estimated to be 4.8 billion yuan.
Mubang Hi-Tech’s 2021 annual report shows that the company mainly has three modules: educational toy business, educational business and medical device business. Mubang Hi-Tech acquired 100% equity of Haoan Energy jointly held by Zhang Zhongan and Yu Jumei in cash in the first half of this year, with a transaction consideration of 980 million yuan. After the transaction is completed, Haoan Energy will become a wholly-owned subsidiary of the listed company.
Haoan Energy is a high-tech enterprise mainly engaged in R&D, production and sales of photovoltaic silicon wafers and silicon rods. Its main products are solar monocrystalline silicon wafers and silicon rods, among which solar monocrystalline silicon wafers are the main ones, and the main specifications of solar monocrystalline silicon wafers are 166mm, 182mm and 210 mm. After the transaction is completed, the company’s main business is to increase the research and development, production and sales of photovoltaic silicon wafers and silicon rods.
After putting Haoan Energy into the bag, Mubang Hi-Tech has made frequent moves in the field of photovoltaic cell production projects.
Mubang Hi-Tech announced on the evening of June 2 that the company signed the Framework Agreement on Investment Strategic Cooperation with the Anyi County People’s Government. Both parties are willing to make full use of their respective resource advantages, and arrange about 300 mu of project land within the industrial park to build 8GWTOPCON photovoltaic cell production project. At present, the company has not formulated a specific investment plan, and the investment amount is still unclear.
At that time, Mubang Hi-Tech suggested in the announcement that the main business of the photovoltaic sector is the research, development, production and sales of monocrystalline silicon rods and silicon wafers, and the silicon wafer products are the upstream materials of photovoltaic cells. At present, the company is not engaged in photovoltaic cell business, nor has TOPCON photovoltaic cell R&D talents and production technology reserves.
However, Mubang Hi-Tech announced at the same time on the evening of August 16th that the company and the Anyi County People’s Government had fully communicated and exchanged views on the promotion of cooperative projects, and no specific cooperation agreement has been formed so far. Through friendly negotiation, the company decided to terminate the Framework Agreement signed with the Anyi County People’s Government.
In addition, Mubang Hi-Tech also announced on the evening of July 20th that it had signed the Investment Contract of 10GW TOPCON Photovoltaic Cell Production Base Project with Wuzhou Municipal People’s Government, with an estimated total investment of 5.2 billion yuan. Mubang Hi-Tech said in this announcement that the relevant talent team is under construction.
Mubang Hi-Tech said in the latest announcement that the company had reached a cooperation with Wuzhou Municipal People’s Government in the early stage and planned to build a 10GW TOPCON photovoltaic cell production base. The company and Wuzhou Municipal People’s Government jointly build a 10GW TOPCON photovoltaic cell production base, which is currently in progress.
Mubang Hi-Tech announced the risk of stock trading on the evening of August 15th, suggesting that the company and Wuzhou Municipal People’s Government jointly built a 10GW TOPCON photovoltaic cell production base, and now it plans to set up a project subsidiary. The investment of this project is large, and there are risks in capital, technology and talent. The project investment amount is much higher than the company’s book monetary fund level, and the fund gap is large, and some funds need government support. Wuzhou municipal government will give corresponding support to the company only after the investment amount, production capacity and output value of the company’s projects reach the agreed standards. The company intends to solve the capital problem by means of bank financing and equity finance. Due to the limited net assets of the company, the financing amount may not reach the expectation, thus there is a risk that the project progress will be less than expected or the project will be stagnant.
*ST Hengyu wins European big orders overseas market, which is expected to promote performance growth.
On the evening of August 16th, *ST Hengyu announced that it had recently signed a product sales contract with a European customer, with a total contract value of 8.3667 million US dollars, or about 56.56 million yuan (including tax). The company said that according to the performance schedule agreed in the contract, it will not have a significant impact on the company’s performance in 2022. If this contract is successfully performed, it is expected to have a positive impact on the company’s operating performance in 2023. At the same time, it is conducive to enhancing the company’s sustainable operation ability and brand influence, and has a positive impact on the company’s exploration of overseas markets.
The announcement shows that the subject matter of this contract is 30,000 tons/year industrial continuous waste tire cracking production line.
According to the data, the new signing amount of *ST Hengyu in the first quarter of 2022 was 128 million yuan, while the new signing amount of the company in 2021 was 190 million yuan. The signing of this overseas order has undoubtedly laid a solid foundation for the company’s future performance growth.
*ST Hengyu is a service provider of industrial continuous cracking production line, and its products are applied to environmental protection fields such as waste tires, waste plastics and oily sludge. The international market is an important source of income for *ST Hengyu. In this year’s business plan, the company stated that it will adhere to and strengthen the "going out" sales strategy, pay attention to the attempts of strategic cooperation within the industry, regional market development cooperation and overseas regional agency cooperation, and enrich and strengthen the construction of the company’s marketing system.
In 2022, *ST Hengyu overseas market progressed smoothly. According to the quarterly report of *ST Hengyu, the company and American customers have started the implementation of the waste plastic cracking production line with a contract amount of US$ 6 million. The customer’s project startup node order has been signed and approved, and the corresponding payment has been paid.
It is worth mentioning that the breakthrough in overseas markets will help *ST Hengyu expand in the field of environmental protection segmentation. Last year’s annual report showed that the Danish waste plastic project of the company’s customer has been recognized by BASF, an international chemical giant. By the end of the first quarter, the company’s overseas customers in hand include Quantafuel AS, British customers and American customers, and their application fields are all industrial continuous waste plastic cracking production lines. (Tan Pengpeng)
Shaanxi Black Cat: The subsidiary donated 300,000 yuan to support local epidemic prevention and control.
() On the evening of August 16th, it was announced that the epidemic situation of COVID-19 in Shandan County of Zhangye City had relapsed recently, and the situation was grim. Under the premise of strictly preventing and controlling the epidemic situation of enterprises, Zhangye Hongneng Coal Industry Co., Ltd., a subsidiary of the company, adheres to the concept that enterprises will grow and repay the society, responds to the call of the local government, and helps the local epidemic prevention and control work with practical actions, and decides to donate 300,000 yuan to the Red Cross Society of Shandan County, Zhangye City to support the development of local epidemic prevention and control.
The company said that this time, Hongneng Coal Industry implemented foreign donations to support the development of local epidemic prevention and control, and passed positive energy with practical actions; This foreign donation is funded by Hongneng Coal’s own funds, and this donation does not have a significant impact on the company’s current and future operating performance.
Zhongheng Group: Obtained the drug registration certificate and the notice of approval for the listing application of chemical raw materials.
On the evening of August 16th, Zhongheng Group announced that Chongqing Laimei Pharmaceutical Co., Ltd., a holding subsidiary, had received the Drug Registration Certificate of esmomeprazole magnesium enteric-coated capsules of 20mg and 40mg approved and issued by National Medical Products Administration, and Chongqing Laimei Longyu Pharmaceutical Co., Ltd., the holding grandson of the company, had received the Notice of Approval for the Listing of Esomeprazole magnesium API approved and issued by National Medical Products Administration.
According to the company, Laimei Pharmaceutical and Laimei Longyu obtained the Drug Registration Certificate of Esomeprazole Magnesium Enteric-coated Capsules (specifications: 20mg, 40mg) and the Notice of Approval for the Listing Application of Esomeprazole Magnesium Bulk Drug, which is conducive to further enriching the company’s product line and increasing the company’s market share of digestive tract drugs.
Mubang Hi-Tech received an inquiry letter from Shanghai Stock Exchange about photovoltaic cell project.
Mubang Hi-Tech announced that on August 16, 2022, the company received the "Inquiry Letter on Investment Framework Agreement of Jiangxi Mubang Hi-Tech Co., Ltd." issued by Shanghai Stock Exchange.
On August 16th, 2022, the company announced that it had signed a strategic cooperation framework agreement with the people’s government of Echeng District, and planned to build a 10GW TOPCON photovoltaic cell production base, with an estimated investment scale of 4.8 billion yuan. At the same time, it terminated the 8GW TOPCON photovoltaic cell production base investment strategic cooperation framework agreement signed with the people’s government of Anyi County.
According to the requirements, the company needs to make supplementary disclosure: (1) The reasons for the termination of the above investment framework agreement, and combined with the previous project demonstration, feasibility study and internal decision-making process, explain whether the previous investment decision was prudent and whether Dong Jiangao performed his duties diligently; (2) Whether the progress of other large-scale investment framework agreements and sales contracts disclosed by the company in the early stage may lead to unexpected or termination risks; (3) According to the actual progress of the project, self-check whether there is an exaggeration of the project scale to mislead investors, and whether there is a situation of using non-binding large-scale investment framework agreements to cater to market hotspots and cooperate with stock price speculation. (4) Since the first disclosure of the relevant framework agreement, the company’s R&D investment in photovoltaic cell projects, investment amount and investment category; (5) In the current situation of lack of production technology reserves and the talent team is still in the preparatory stage, the reasons and commercial rationality of the proposed large investment are frequently disclosed.
Mubang Hi-Tech plans to build a 10GW TOPCON photovoltaic cell production base project with 4.8 billion yuan.
Mubang Hi-Tech announced that the company has signed the Strategic Cooperation Framework Agreement with the government of Echeng District, and plans to arrange about 500 mu of project land in the government park of Echeng District to build a 10GW TOPCON photovoltaic cell production base project. The investment scale of the project is estimated to be 4.8 billion yuan.
On the same day, the company announced that on June 2, 2022, the company signed the Framework Agreement on Investment Strategic Cooperation with Anyi County Government, and planned to arrange about 300 mu of land for the project within the industrial park to build an 8GWTOPCON photovoltaic cell production project. After the signing of the Framework Agreement, the company and Anyi county government have fully communicated and exchanged views on the promotion of this cooperation project, and no specific cooperation agreement has been formed so far. Through friendly negotiation, the company decided to terminate the Framework Agreement signed with Anyi County Government.
[Company Report]
It is planned to spend 4.475 billion yuan to set foot in photovoltaic cells.
Another company crosses the field of TOPCON photovoltaic cells. On August 4th, Mubang Hi-Tech announced that the board of directors of the company reviewed and approved the Proposal on the Company’s Foreign Investment in the Construction of a 10 GW TOPCON Photovoltaic Cell Production Base Project, etc., and made it clear that the company’s investment in this project is expected to be 4.475 billion yuan, and it is planned to set up a wholly-owned subsidiary in Wuzhou High-tech Zone, Guangxi Zhuang Autonomous Region to operate the project. This means that the company’s investment in the field of TOPCON photovoltaic cells has reached a new level. (Shanghai Securities Journal reporter Li Xingcai)
Mubang Hi-Tech plans to invest 5.2 billion yuan to build a 10GW TOPCON photovoltaic cell production base project.
Mubang Hi-Tech announced on July 20th that the company signed the Investment Contract of 10GW TOPCON Photovoltaic Cell Production Base Project with Wuzhou Municipal Government, and the project name was "10GW TOPCON Photovoltaic Cell Production Base". It is estimated that the total investment of the project is 5.2 billion yuan, of which the investment in production equipment is about 2.775 billion yuan. The project will build about 200,000 square meters of standard factory buildings and supporting buildings, and a 10GW TOPCON photovoltaic cell production line, mainly engaged in the production of TOPCON photovoltaic cells, with an annual production capacity of about 10GW.
70 million shares held by the controlling shareholder of Blu-ray Development will be auctioned.
On August 16th, Sichuan Blu-ray Development Co., Ltd. (referred to as "Blu-ray Development") announced that some shares of the company held by its controlling shareholder Blu-ray Investment Holding Group Co., Ltd. (referred to as "Blu-ray Group") will be publicly auctioned in September.
According to the announcement, as of August 15, 2022, Blu-ray Group held about 1.048 billion shares of Blu-ray Development, accounting for 34.53% of the company’s total share capital. The shares auctioned this time are 70 million shares of Blu-ray Development held by Blu-ray Group, accounting for 2.31% of the company’s total share capital. The applicant for the auction is China Railway Trust Co., Ltd., and the reason for the auction is the default disposal of stock pledge.
The announcement shows that the auction is still in the publicity stage, and the follow-up may involve bidding, payment, court execution of legal procedures, equity change and transfer, and there is some uncertainty. According to the final results, the company will fulfill the corresponding information disclosure obligations according to law. In addition, if this auction is successful, it will not lead to changes in the controlling shareholder and actual controller of Blu-ray Development for the time being.
On the same day, Blu-ray Development announced another announcement that the deviation of the closing price increase of Blu-ray Development shares for three consecutive trading days on August 12, 15 and 16, 2022 reached 20%, which is an abnormal fluctuation of stock trading according to the relevant provisions of the Trading Rules of Shanghai Stock Exchange.
Blu-ray Development said in the announcement that there has been no substantial progress in the corporate debt restructuring plan. As of June 30, 2022, the total amount of debt principal and interest that Blu-ray Development failed to repay due was 38.775 billion yuan, which had a great impact on the company’s operation and financing. Up to now, the relevant debt restructuring plan is still being worked out, and no substantial progress has been made. In terms of business performance, Blu-ray Development expects the net profit attributable to shareholders of listed companies to be around-4.6 billion yuan in the first half of 2022.
In addition, recently, some media reported that Blu-ray Development cooperated with Guangdong Ouhao Group Co., Ltd. to establish Chengdu Oulan Photovoltaic Co., Ltd. to carry out photovoltaic projects. According to Blu-ray Development, Chengdu Oulan Photovoltaic Co., Ltd. is registered recently with a registered capital of 100 million yuan, and the shareholding ratio of Blu-ray Development is 30% (non-holding), which has not been paid. At present, relevant resources and technical personnel have not been equipped, and there are no cooperation projects. There are uncertainties in the follow-up. In addition to the above matters, the controlling shareholder and actual controller of Blu-ray Development have no other important matters or information that should be disclosed but not disclosed that affect the abnormal fluctuation of the company’s stock trading.
Editor Yang Juanjuan
Proofread Li Ming
Jianmin Group: It is planned to acquire 100% equity of Huafang Medical and Care and wholly hold Huafang Hospital.
() On the evening of August 16th, it was announced that the company intends to acquire 100% equity of Zhejiang Huafang Medical Care Co., Ltd. held by related party Huali Pharmaceutical Group Co., Ltd., with a total transaction price of 15,204,400 yuan. The main asset of Huafang Medical is its wholly-owned subsidiary Huafang Hospital, and the company will wholly control Huafang Hospital through the transfer of equity of Huafang Medical. This equity transfer is conducive to accelerating the regional layout of the company’s TCM diagnosis and treatment. In addition, the company intends to subscribe for the fund share of Hangzhou Chaosheng Phase II Venture Capital Partnership (Limited Partnership) as a limited partner of 20 million yuan.
Shengxiang Bio: shareholders holding more than 5% of shares intend to reduce their holdings by no more than 11.77 million shares; shareholders holding more than 5% of shares intend to reduce their holdings by no more than 11.77 million shares.
Last night, Shengxiang Bio announced the plan of centralized bidding for shareholders holding more than 5% shares to reduce their shares. Due to its own capital demand, the shareholder Anhui Zhidao Investment Co., Ltd. (hereinafter referred to as "Anhui Zhidao") intends to reduce its holdings of Shengxiang Bio-shares by centralized bidding, accounting for 2.00% of the company’s total share capital, and it will be implemented within 6 months after 15 trading days from the date of release of the reduction plan, and the total number of shares reduced within 90 consecutive days will not exceed 1% of the company’s total shares.
As of the disclosure date of the announcement, Anhui Zhidao holds 29,987,768 shares of Shengxiang Bio, accounting for 5.10% of the total shares of the company. The shares held by Anhui Zhidao were listed and circulated on August 30, 2021.
Shengxiang Bio: shareholders holding more than 5% of shares intend to reduce their holdings by no more than 11.77 million shares; shareholders holding more than 5% of shares intend to reduce their holdings by no more than 11.77 million shares.
Last night, Shengxiang Bio announced the plan of centralized bidding for shareholders holding more than 5% shares to reduce their shares. Due to its own capital demand, the shareholder Anhui Zhidao Investment Co., Ltd. (hereinafter referred to as "Anhui Zhidao") intends to reduce its holdings of Shengxiang Bio-shares by centralized bidding, accounting for 2.00% of the company’s total share capital, and it will be implemented within 6 months after 15 trading days from the date of release of the reduction plan, and the total number of shares reduced within 90 consecutive days will not exceed 1% of the company’s total shares.
As of the disclosure date of the announcement, Anhui Zhidao holds 29,987,768 shares of Shengxiang Bio, accounting for 5.10% of the total shares of the company. The shares held by Anhui Zhidao were listed and circulated on August 30, 2021.
Shengxiang Bio: Shareholders holding more than 5% of shares intend to reduce their holdings by no more than 11.77 million shares.
Last night, Shengxiang Bio announced the plan of centralized bidding for shareholders holding more than 5% shares to reduce their shares. Due to its own capital demand, the shareholder Anhui Zhidao Investment Co., Ltd. (hereinafter referred to as "Anhui Zhidao") intends to reduce its holdings of Shengxiang Bio-shares by centralized bidding, accounting for 2.00% of the company’s total share capital, and it will be implemented within 6 months after 15 trading days from the date of release of the reduction plan, and the total number of shares reduced within 90 consecutive days will not exceed 1% of the company’s total shares.
As of the disclosure date of the announcement, Anhui Zhidao holds 29,987,768 shares of Shengxiang Bio, accounting for 5.10% of the total shares of the company. The shares held by Anhui Zhidao were listed and circulated on August 30, 2021.
(Editor: Jiang Ninglu)
Shengxiang Bio: Shareholders holding more than 5% of shares intend to reduce their holdings by no more than 11.77 million shares.
Last night, Shengxiang Bio announced the plan of centralized bidding for shareholders holding more than 5% shares to reduce their shares. Due to its own capital demand, the shareholder Anhui Zhidao Investment Co., Ltd. (hereinafter referred to as "Anhui Zhidao") intends to reduce its holdings of Shengxiang Bio-shares by centralized bidding, accounting for 2.00% of the company’s total share capital, and it will be implemented within 6 months after 15 trading days from the date of release of the reduction plan, and the total number of shares reduced within 90 consecutive days will not exceed 1% of the company’s total shares.
As of the disclosure date of the announcement, Anhui Zhidao holds 29,987,768 shares of Shengxiang Bio, accounting for 5.10% of the total shares of the company. The shares held by Anhui Zhidao were listed and circulated on August 30, 2021.
(Editor: Jiang Ninglu)
Jianmin Group intends to acquire 100% equity of Huafang Medical to wholly control Huafang Hospital.
Jianmin Group announced that the company intends to further increase the upstream and downstream industrial chain layout of the big health business, and realize the diversification of services in the big health business field and the effective extension of the business field. The company intends to transfer all the equity of Zhejiang Huafang Medical Co., Ltd. held by related parties with its own funds, and the company’s transfer of equity this time constitutes a related party transaction.
This time, the company intends to acquire 72.67%, 21.65% and 5.68% of the shares of Zhejiang Huafang Medical Co., Ltd. held by Huali Pharmaceutical Group Co., Ltd., Zhejiang Huali Investment Management Co., Ltd. and Suzhou Yuanyi Zhiyuan Equity Investment Partnership (Limited Partnership) with its own funds, and the transaction price of the shares totals 15.2044 million yuan.
The main asset of Huafang Medical, the subject of this transaction, is its wholly-owned subsidiary, Hangzhou Huafang Hospital Co., Ltd. (hereinafter referred to as Huafang Hospital). This transaction company will wholly control Huafang Hospital by acquiring 100% equity of Huafang Medical. Huafang Hospital is a comprehensive hospital established according to the second-class standard. The hospital is fully equipped and has more than 10 clinical medical departments, among which anorectal, traditional Chinese medicine and gynecology are well developed.
Luwei Optoelectronics listed today at a price of 25.08 yuan/share.
According to the announcement of the exchange, Luwei Optoelectronics was listed in science and technology innovation board of Shanghai Stock Exchange today, with the company’s stock code of 688401, the issue price of 25.08 yuan/share and the issue price-earnings ratio of 70.31 times.
